Data Foundry

Drug recalls 2020

Lisinopril Tablets — Class II drug recall D-1290-2020

Terminated recall by Lupin Pharmaceuticals Inc., reported 2020-06-17, distributed nationwide. Product Mix Up: Lisinopril 10 mg tablets were found in Lisinopril 5 mg 1000-count bottle.

Recall numberD-1290-2020
Product typeDrug
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmLupin Pharmaceuticals Inc., Baltimore, MD, United States
Recall initiated2020-05-28
Classified2020-06-08
Reported by FDA2020-06-17
Terminated2021-05-04
DistributedNationwide (US)
Quantity4,224 bottles
NDC68180-0512, 68180-0512-01, 68180-0512-02, 68180-0512-03, 68180-0512-09, 68180-0512-30, 68180-0513, 68180-0513-01, 68180-0513-02, 68180-0513-03, 68180-0513-05, 68180-0513-09, 68180-0513-30, 68180-0514, 68180-0514-01, 68180-0514-02, 68180-0514-03, 68180-0514-05, 68180-0514-09, 68180-0514-30, 68180-0515, 68180-0515-01, 68180-0515-02, 68180-0515-03, 68180-0515-05 and 40 more
Lot numbersQ900683
Expiration dates2022-10-31

Product

Lisinopril Tablets, USP, 5 mg, Rx Only, 1000-count bottle, Manufactured for: Lupin Pharmaceuticals Inc., Baltimore, MD 21202, Manufactured by: Lupin Limited, Nagpur - 441 108, India, NDC 68180-513-03.

Reason for recall

Product Mix Up: Lisinopril 10 mg tablets were found in Lisinopril 5 mg 1000-count bottle.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1290-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.